Targeting JNK for the diagnosis and treatment of Alzheimer's disease
Alzheimer's disease (AD) affects over half million people in Spain and it is estimated that there are two million people directly related to the disease. Although AD etiology is still unknown, it seems is to be associated to neuronal apoptosis and synaptic terminals loss, resulting in neuroinfl...
Main Authors: | Vela-Lumbreras, S. (Silvia), Ramirez, M.J. (María Javier), Solas, M. (Maite) |
---|---|
Format: | info:eu-repo/semantics/doctoralThesis |
Language: | eng |
Published: |
2018
|
Subjects: | |
Online Access: | https://hdl.handle.net/10171/50971 |
Similar Items
-
The compound 33i, a new SIRT2 inhibitor, as a potential treatment for Alzheimer’s disease
by: Díaz-Perdigón, T. (Teresa), et al.
Published: (2019) -
Adrenomedullin, a new therapeutic target for the treatment of Alzheimer's disease
by: Ferrero-Hidalgo, H. (Hilda), et al.
Published: (2018) -
Unravelling the role of SIRT2 in Alzheimer’s disease
by: Sola-Sevilla, N. (Noemi), et al.
Published: (2023) -
Design and in vitro / in vivo evaluation of a targeted immunotherapy platform for the treatment of melanoma
by: Merino-Díaz, M. (María), et al.
Published: (2019) -
Deciphering the connection between aging, insulin resistance and cognitive decline in Alzheimer's disease: role of TMAO as linking mechanism
by: Janeiro-Arenas, M.H. (Manuel Humberto), et al.
Published: (2023)